Scientists at Doherty have been researching garlic properties over the past 18 months and have discovered a certain Australian-grown garlic variety demonstrates antiviral properties with up to 99.9 per cent efficacy against the viruses which cause COVID-19 and the common flu.
The world-first research, commissioned by the Australian Garlic Producers organisation, involved in-vitro testing against the SARS-CoV-2 and Influenza type A viruses, using garlic ingredients extracted from exclusive Australian-grown garlic varieties.
The most efficacious garlic varieties and their extracted proprietary ingredients are being commercialised. They can be taken as a soft capsule supplement similar to vitamin C or fish oil and are subject to a recently lodged International Patent.